Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 48 | 03/08/20 | |
Susan Blum
DFI | Director of Finance/CFO | 52 | 01/01/16 |
Compliance Officer | 45 | - | |
Jisoo Park
PRN | Corporate Officer/Principal | - | 06/07/21 |
Kristen Allgor
HRO | Human Resources Officer | - | 16/11/20 |
John Harlow
PRN | Corporate Officer/Principal | - | 30/03/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 20/04/20 |
Director/Board Member | - | 20/04/20 | |
Director/Board Member | - | 20/04/20 | |
Compliance Officer | 45 | - | |
Chief Executive Officer | 48 | 03/08/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 13 750 691 | 13 578 334 ( 98,75 %) | 0 | 98,75 % |
Coordinate società
Melinta Therapeutics, Inc.
389 Interpace Parkway Suite 450
07054, Parsippany
+908-617-1300
http://melinta.com![Indirizzo Melinta Therapeutics, Inc.](https://cdn.zonebourse.com/static/address/55178946.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+18,43% | 124 Mrd | |
+19,81% | 114 Mrd | |
+19,56% | 25,83 Mrd | |
-23,74% | 19,42 Mrd | |
-18,19% | 16,2 Mrd | |
-19,97% | 15,31 Mrd | |
+57,08% | 14,32 Mrd | |
+7,95% | 14,31 Mrd | |
-49,33% | 14,19 Mrd |